Chantrix Tablets Help Smokers Stop Smoking

According to the Centers for Disease Control and Prevention (CDC), an estimated 44.5 million adults in the United States smoke cigarettes and more than 8.6 million of them have at least one serious illness caused by smoking. Chantrix is a tablet that help smokers quit smoking by acting at sites in the brain affected by nicotine. By doing so, it may help those who wish to give up smoking in by providing some nicotine effects to ease the withdrawal symptoms and by blocking the effects of nicotine from cigarettes if they resume smoking. The FDA has announced the approval of Chantrix tablets to help cigarette smokers stop smoking.

Chantrix is manufactured and distributed by Pfizer, Inc., New York, NY. The active ingredient is varenicline tartrate which is a new molecular entity that received a priority FDA review because of its significant potential benefit to public health. The approved course of Chantrix treatment is for 12 weeks. Patients are encouragned to continue with an additional 12 weeks of Chantrix treatment to further increase the likelihood of long-term smoking cessation even though they have successfully quit smoking during the first Chantrix treatment.

In clinical trials, the most common adverse effects of Chantrix were nausea, headache, vomiting, flatulence (gas), insomnia, abnormal dreams and dysgeusia. CHANTIX should be taken after eating. Some important guidelines of taking Chantrix include: to drink a full glass of water with it. If you miss a dose, take it as soon as you remember. If it's close to the time of your next dose, wait. Then just take your next regular dose. Be sure to tell your doctor about all other medications you are taking before starting Chantrix. It is important to tell your doctor if you take insulin, asthma medications, or blood thinners because when you stop smoking, there may be a change in how these and other medicines work for you.